About Glycemicon
Glycemicon is a company based in Brugg (Switzerland) founded in 2012. It operates as a D2C, B2B, and B2C. Glycemicon has raised $5.28 million across 3 funding rounds from investors including Venture Kick. Glycemicon offers products and services including Nitroethane, 2-Bromo 4-methylpropiophenone, Benzaldehyde, T Connectors, and Y Connectors. Glycemicon operates in a competitive market with competitors including Sana Biotechnology, Kriya Therapeutics, Semma Therapeutics, Cellino and Adocia, among others.
- Headquarter Brugg, Switzerland
-
Sectors
Industrial Goods & ManufacturingChemicals & Materials
-
Phone
*********
-
Website
*********
- Legal Name Webster Inc S.R.O.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.28 M (USD)
in 3 rounds
-
Latest Funding Round
$1.88 M (USD), Series A
Apr 05, 2018
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glycemicon
Glycemicon offers a comprehensive portfolio of products and services, including Nitroethane, 2-Bromo 4-methylpropiophenone, Benzaldehyde, T Connectors, and Y Connectors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Organic solvent for reactions and syntheses in chemical processes.
Intermediate used in pharmaceutical and industrial manufacturing.
Aromatic aldehyde for flavoring and chemical synthesis applications.
Polypropylene connectors for tubing in lab experiments and setups.
Barbed fittings for secure tubing connections in scientific work.
Funding Insights of Glycemicon
Glycemicon has successfully raised a total of $5.28M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $1.88 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $1.9M
-
First Round
First Round
(29 Jan 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series A - Glycemicon | Valuation |
investors |
|
| Feb, 2017 | Amount | Series A - Glycemicon | Valuation |
investors |
|
| Jan, 2013 | Amount | Seed - Glycemicon | Valuation | Venture Kick |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glycemicon
Glycemicon has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glycemicon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glycemicon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glycemicon Comparisons
Competitors of Glycemicon
Glycemicon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Kriya Therapeutics, Semma Therapeutics, Cellino and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Glycemicon
When was Glycemicon founded?
Glycemicon was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Glycemicon located?
Glycemicon is headquartered in Brugg, Switzerland. It is registered at Brugg, Aargau, Switzerland.
Is Glycemicon a funded company?
Glycemicon is a funded company, having raised a total of $5.28M across 3 funding rounds to date. The company's 1st funding round was a Seed of $140.14K, raised on Jan 29, 2013.
What does Glycemicon do?
Glycemicon operates as an online chemical store, providing a variety of chemicals, laboratory glassware, and supplies to individuals and companies. Based in the Czech Republic, they ensure products are thoroughly checked and safely delivered globally. They accept Bitcoin payments and focus on high-quality items for research and industrial use, shipping to countries like the US, EU, and Asia.
Who are the top competitors of Glycemicon?
Glycemicon's top competitors include Sana Biotechnology, Semma Therapeutics and Adocia.
What products or services does Glycemicon offer?
Glycemicon offers Nitroethane, 2-Bromo 4-methylpropiophenone, Benzaldehyde, T Connectors, and Y Connectors.
Who are Glycemicon's investors?
Glycemicon has 1 investor. Key investors include Venture Kick.